Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/05/2015 | US20150037399 Novel use of pipoxolan and its pharmaceutical composition |
02/05/2015 | US20150037398 Molecule mixture comprising an amphipathic molecule type a, which has a positive total charge in the hydrophilic range, and an amphipathic molecule type b and a polyphenol c, method for producing said molecule mixture and use thereof |
02/05/2015 | US20150037396 Targeted Delivery of Anti-Fungal Agents |
02/05/2015 | US20150037395 Transdermal hormone delivery system: compositions and mtehods |
02/05/2015 | US20150037391 Local administration of gallium compositions to treat pain |
02/05/2015 | US20150037388 Edible slow dissolving film for treating oral ulcerations |
02/05/2015 | US20150037386 Compositions and methods for promoting bone formation |
02/05/2015 | US20150037378 Anti-Microbial Formulations Containing Nitric Oxide |
02/05/2015 | US20150037377 Substituted cellulose acetates and uses thereof |
02/05/2015 | US20150037372 pH-Responsive High-Density Lipoprotein-Like Particle Complex |
02/05/2015 | US20150037360 Lysosome-Cleavable Linker |
02/05/2015 | US20150037357 Immune stimulation/metabolic inhibition as antitumor therapy |
02/05/2015 | US20150037351 Novel therapeutic target for the prevention of tumour metastasis |
02/05/2015 | US20150037341 Diagnostic and Therapeutic Method |
02/05/2015 | US20150037336 Combination of hb-egf binding protein and egfr inhibitor |
02/05/2015 | US20150037332 Treatment of metastic breast cancer |
02/05/2015 | US20150037329 Method of reducing titers of antibodies specific for a therapeutic agent |
02/05/2015 | US20150037325 Slit-robo signaling for diagnosis and treatment of kidney disease |
02/05/2015 | US20150037320 Treatment of macrophage-related disorders |
02/05/2015 | US20150037318 Treatment of multiple sclerosis with combination of laquinimod and flupirtine |
02/05/2015 | US20150037313 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
02/05/2015 | US20150037309 Preparation for improving the action of receptors |
02/05/2015 | US20150037308 Pyrroloquinoline quinone alcohol adduct |
02/05/2015 | US20150037295 Methods of inducing tissue regeneration |
02/05/2015 | US20150037291 Compositions and methods for cell transplantation |
02/05/2015 | US20150037282 D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease |
02/05/2015 | US20150037280 Substituted pyrazolone compounds and methods of use |
02/05/2015 | US20150037276 Hydrocolloid composition and an article containing the same |
02/05/2015 | US20150037275 Rifaximin complexes |
02/05/2015 | US20150037263 Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
02/05/2015 | US20150037252 Method for the Treatment of a Solid Tumour |
02/05/2015 | US20150037249 Uses of porous nanostructure in delivery |
02/05/2015 | US20150034087 Low Dose Pharmaceutical Composition Comprising Zanamivir |
02/05/2015 | DE102013012800A1 Verwendung eienr Naturstoffmischung zur Bekämpfung von neurodegenerativen Erkrankungen bei Mensch und Tier Use eienr natural product mix to combat neurodegenerative diseases in humans and animals |
02/04/2015 | EP2832860A1 Nucleic acid molecule capable of inhibiting expression of periostin gene, method for inhibiting expression of periostin gene, and use of said nucleic acid molecule |
02/04/2015 | EP2832740A1 SALT OF 1-(2-DEOXY-2-FLUORO-4-THIO-beta-D-ARABINOFURANOSYL)CYTOSINE |
02/04/2015 | EP2832734A1 Heterocyclic compound |
02/04/2015 | EP2832733A1 4-alkanoylamino-3-pyrazolone derivative |
02/04/2015 | EP2832732A1 Ppars agonist activity enhancing drug |
02/04/2015 | EP2832731A1 Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity |
02/04/2015 | EP2832730A1 Mirabegron-containing pharmaceutical composition |
02/04/2015 | EP2832728A1 Triazinone compound and t-type calcium channel inhibitor |
02/04/2015 | EP2832726A1 (2-heteroarylamino)succinic acid derivative |
02/04/2015 | EP2832725A1 Aromatic ring compound |
02/04/2015 | EP2832724A1 Nipecotic acid derivative and use thereof for medical purposes |
02/04/2015 | EP2832722A1 Fused azole derivative |
02/04/2015 | EP2832720A1 1,2-disubstituted cyclobutyl compounds |
02/04/2015 | EP2832373A1 Method to block site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis |
02/04/2015 | EP2832370A1 Method for producing drugs and biologically active agents |
02/04/2015 | EP2832369A1 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy |
02/04/2015 | EP2832367A1 Agent for preventing or treating giant cell tumor or chondrosarcoma arising in bone/soft tissue |
02/04/2015 | EP2832360A1 Polysaccharide for use in preventing metastasis formation and/or relapse |
02/04/2015 | EP2832359A1 Diquafosol-containing eye drop |
02/04/2015 | EP2832358A1 Pharmaceutical kit for use in the treatment of colon and colorectal cancer |
02/04/2015 | EP2832357A1 Selective AT2 receptor agonists for use in treatment of cachexia |
02/04/2015 | EP2832356A1 Administration of a therapeutic amount of genistein to mitigate erectile dysfunction resulting from radiation therapy for prostate cancer |
02/04/2015 | EP2832355A1 Anticancer agent |
02/04/2015 | EP2832354A1 Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne |
02/04/2015 | EP2832351A1 Multilayer Tablet Formulations Comprising Tenofovir and Entecavir |
02/04/2015 | EP2832349A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
02/04/2015 | EP2832344A1 Composition, and external preparation for the skin or functional food each containing said composition |
02/04/2015 | EP2831237A1 High molecular weight heparosan polymers and methods of production and use thereof |
02/04/2015 | EP2831233A1 Compositions and treatments based on cadherin modulation |
02/04/2015 | EP2831161A1 Fungicide formulations for plasticized pvc |
02/04/2015 | EP2831160A1 Stable compositions of thiabendazole and iodine-containing fungicides |
02/04/2015 | EP2831094A1 Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses |
02/04/2015 | EP2831083A1 Anti-inflammatory macrolides |
02/04/2015 | EP2831081A1 Functionalized porous silicon nanoparticles and use thereof in photodynamic therapy |
02/04/2015 | EP2831080A1 Lactam kinase inhibitors |
02/04/2015 | EP2831079A1 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof |
02/04/2015 | EP2831077A1 Bicyclic pyrazinone derivatives |
02/04/2015 | EP2831075A1 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
02/04/2015 | EP2831074A1 Novel pyrazolopyrimidines |
02/04/2015 | EP2831073A2 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b]pyridine compounds as modulators of c-met protein kinases |
02/04/2015 | EP2831070A1 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process |
02/04/2015 | EP2831069A1 ISOXAZOLE beta-LACTAMASE INHIBITORS |
02/04/2015 | EP2831067A1 Small molecule inhibitors of mcl-1 and uses thereof |
02/04/2015 | EP2831066A1 Benzofuran derivatives for the treatment of hepatitis c |
02/04/2015 | EP2831064A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists |
02/04/2015 | EP2831063A1 Schweinfurthin analogues |
02/04/2015 | EP2831061A1 Triazole derivatives as hsp90 inhibitors |
02/04/2015 | EP2831060A1 Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
02/04/2015 | EP2831056A1 New anti-mycobacterial drugs against tuberculosis |
02/04/2015 | EP2831053A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists |
02/04/2015 | EP2831045A2 An improved process for the preparation of etoricoxib |
02/04/2015 | EP2831043A1 Novel compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system |
02/04/2015 | EP2831042A1 Heteroaryl compounds with a-cyclic bridging unit |
02/04/2015 | EP2831041A2 Tcr/mhcii-collagen interaction inhibitors useful for the treatment of rheumatoid arthritis |
02/04/2015 | EP2831039A1 Salicylic acid derivatives useful as glucocerebrosidase activators |
02/04/2015 | EP2831034A1 Anti-metatstatic agents predicated upon polyamine-macrocyclic conjugates |
02/04/2015 | EP2830712A1 Methods for modulating cell-mediated immunity using human milk oligosaccharides |
02/04/2015 | EP2830666A1 Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy |
02/04/2015 | EP2830664A1 Administration of a raf inhibitor and a mek inhibitor in the treatment of melanoma |
02/04/2015 | EP2830657A1 Treatment of acute inflammation in the respiratory tract |
02/04/2015 | EP2830648A1 Methods for treating neoplasia |
02/04/2015 | EP2830636A1 Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives |
02/04/2015 | EP2830635A1 Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
02/04/2015 | EP2830634A1 Method for treatment of labor arrest |
02/04/2015 | EP2830633A1 Combination therapy for the treatment of cancer |
02/04/2015 | EP2830632A1 Parenteral formulations for administering macrolide antibiotics |